Login
$LGND
$311.73 +$3.43 (1.11%) Close

$LGND 4/A SEC Filings

Filed On Filing
07 Nov 2022 Form 4/A: Higgins John L, Director

Holds 426,731 shares of Common Stock

22 Sep 2022 Form 4/A: Higgins John L, Director

Sold 1,000 shares ($88.1K)

28 Aug 2020 Form 4/A: Ligand Pharmaceuticals Inc, 10% owner · Viking Therapeutics, Inc.

Sold 148,700 shares ($1.21M)

24 Sep 2019 Form 4/A: Higgins John L, Director

Acquired 0 0.75% Convertible Senior Notes due 2023 (Open Market Purchase)

03 Jul 2018 Form 4/A: Aryeh Jason, Director

Granted 2,474 Non-Qualified Stock Option (right to buy)

03 Jul 2018 Form 4/A: Davis Todd C, Director

Granted 2,474 Non-Qualified Stock Option (right to buy)

03 Jul 2018 Form 4/A: Gray Nancy Ryan, Director

Granted 2,474 Non-Qualified Stock Option (right to buy)

03 Jul 2018 Form 4/A: Kozarich John W, Director

Granted 2,474 Non-Qualified Stock Option (right to buy)

03 Jul 2018 Form 4/A: Lamattina John L, Director

Granted 2,474 Non-Qualified Stock Option (right to buy)

03 Jul 2018 Form 4/A: Patel Sunil, Director

Granted 2,474 Non-Qualified Stock Option (right to buy)

03 Jul 2018 Form 4/A: Sabba Stephen L, Director

Received 493 shares as a grant or award · Granted 2,474 Non-Qualified Stock Option (right to buy)

09 Sep 2016 Form 4/A: Kozarich John W, Director

Received 1,666 shares by exercise or conversion ($76K)

28 Apr 2015 Form 4/A: Sabba Stephen L, Director

Received 925 shares as a grant or award · Granted 2,754 Non-Qualified Stock Option (right to buy)

18 Mar 2015 Form 4/A: Berkman Charles S, VP, Gen. Counsel & Secretary

Acquired 126 shares (Other Transaction) ($5.7K)

25 Feb 2015 Form 4/A: Herman Melanie J, Director of Accounting

Acquired 103 shares (Other Transaction) ($4.66K)

14 Oct 2014 Form 4/A: Sabba Stephen L, Director

Bought 2,000 shares ($86.2K)

14 Oct 2014 Form 4/A: Knott David M, Director

Bought 4,000 shares ($172K)

04 Jun 2013 Form 4/A: Higgins John L, Director

Received 6,000 shares as a grant or award · Granted 160,666 Non-Qualified Stock Option (right to buy) ($2.32M)

04 Jun 2013 Form 4/A: Foehr Matthew W, EVP and COO

Received 16,667 shares as a grant or award · Granted 51,546 Non-Qualified Stock Option (right to buy) ($514K)

19 Nov 2012 Form 4/A: Bvf Partners L P/IL, 10% owner and 5 others

Bought 12,515 shares ($191K) · Bought 4,076 shares ($61.1K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support